The ExTINGUISH Trial for NMDAR Encephalitis

Stacey Clardy, MD, PhD

Stacey Clardy is the principal investigator (PI) of an NIH U01 grant (via the NeuroNEXT Clinical Trials Network) to fund the ExTINGUISH Trial – the first NIH-funded, prospective, international, randomized clinical trial for NMDA receptor encephalitis, at 25 US sites and 2 European sites, with enrollment currently ongoing. She established the Autoimmune Neurology Clinic at the University of Utah ten years ago – one of the few clinics in the United States focused on serving this group of patients. Dr. Clardy is also the director of the Autoimmune Neurology Fellowship program, and the editor of the Neurology Podcast for the journal Neurology and the Neurology Minute for the American Academy of Neurology.

---